Log in to search using one of your social media accounts:

 

Three or more cups of coffee daily halves mortality risk in patients with both HIV and HCV

(Elsevier) Patients infected by both HIV and hepatitis C virus are at specific risk of end-stage liver disease and greater risk of cardiovascular diseases and cancer. In addition, HIV infection accelerates the progression of chronic hepatitis C to fibrosis and development of cirrhosis and end-stage liver disease. In these HIV-HCV co-infected patients, drinking at least three cups of coffee each day halved the risk of all-cause mortality according to a new study published in the Journal of Hepatology.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news

Related Links:

This study aims to describe the clinical characteristics of HCV-infected patients during initial presentation to tertiary care in Malaysia, a middle-income Asian country, to inform the development of a national guideline.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research
We enter an era when NASH is becoming a main cause of liver mortality and morbidity: a main cause of cirrhosis, a main cause of decompensated cirrhosis and end-stage liver disease [1], a main cause of primary liver cancer[2,3], a main cause of listing for liver transplantation [1,4]. It took a long time for this to be accepted ([5 –8]) although there was precedent with hepatitis C: as surprising as it may seem nowadays, back one to two decades ago, arguments have been raised against HCV infection as a significant cause of serious liver disease [9–11].
Source: Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
Testa Liver cancer is the second most common cause of cancer-related death. The major forms of primary liver cancer are hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). Both these tumors develop against a background of cirrhotic liver, non-alcoholic fatty liver disease, chronic liver damage and fibrosis. HCC is a heterogeneous disease which usually develops within liver cirrhosis related to various etiologies: hepatitis B virus (HBV) infection (frequent in Asia and Africa), hepatitis C virus (HCV), chronic alcohol abuse, or metabolic syndrome (frequent in Western countries). In cirrhosis, hepa...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
Authors: Ghouri YA, Mian I, Rowe JH Abstract Since the 1970s, the epidemic of hepatocellular carcinoma (HCC) has spread beyond the Eastern Asian predominance and has been increasing in Northern hemisphere, especially in the United States (US) and Western Europe. It occurs more commonly in males in the fourth and fifth decades of life. Among all cancers, HCC is one of the fastest growing causes of death in the US and poses a significant economic burden on healthcare. Chronic liver disease due to hepatitis B virus or hepatitis C virus and alcohol accounts for the majority of HCC cases. Incidence of nonalcoholic fatty...
Source: Journal of Carcinogenesis - Category: Cancer & Oncology Tags: J Carcinog Source Type: research
Abstract Answer questions and earn CME/CNE Chronic hepatitis C virus (HCV) infection affects millions of people worldwide and is associated with cancer. Direct-acting antivirals (DAAs) have changed HCV treatment paradigms, but little is known about the management of HCV infection in patients with cancer. The substantial burden of HCV infection and the inconclusive evidence regarding its detection and management in patients with cancer prompted the authors to review the literature and formulate recommendations. Patients for whom HCV screening is recommended included all patients with hematologic malignancies, hemat...
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Tags: CA Cancer J Clin Source Type: research
Chronic hepatitis C virus (HCV) infection is characterized by progressive liver damage and fibrosis, which can lead to liver failure or hepatocellular carcinoma [1]. In 2013, an estimated 357,800 people worldwide died from HCV-related cirrhosis, and an additional 342,500 people died from liver cancer caused by HCV [2]. The burden of HCV-associated liver disease is projected to continue to increase in many countries in the coming decades [3].
Source: Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
Chronic hepatitis C virus (HCV) infection is characterized by progressive liver damage and fibrosis, which can lead to liver failure or hepatocellular carcinoma.1 In 2013, an estimated 357,800 people worldwide died from HCV-related cirrhosis, and an additional 342,500 people died from liver cancer caused by HCV.2 The burden of HCV-associated liver disease is projected to continue to increase in many countries in the coming decades.3
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Research Article Source Type: research
ConclusionsHepatocellular carcinoma patients with prior SVR and compensated cirrhosis at the time of tumour diagnosis have prolonged OS than viraemic patients. Given the lack of cirrhosis progression, no SVR patient ultimately died for ESLD while this condition appears the main cause of death among viraemic patients.
Source: Liver International - Category: Gastroenterology Authors: Tags: ORIGINAL ARTICLE Source Type: research
Authors: Lombardi A, Grimaldi A, Zappavigna S, Misso G, Caraglia M Abstract HCC is the third leading cause of cancer-related deaths worldwide, accounting for about 1 million deaths annually. The incidence of HCC is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and hepatitis C strongly predisposes to the development of chronic liver disease and subsequent development of HCC. Patients with HCC generally present at an advanced stage due to compensated cirrhosis defined by the absence of pathognomonic symptoms, resulting in death within 6 to 20 months, suggesting an urgent need in treatme...
Source: Minerva Gastroenterologica e Dietologica - Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research
Viral liver diseases are frequent comorbidities and major contributors to death in HIV-positive individuals on antiretroviral therapy. Although cure of hepatitis C and control of hepatitis B with antivirals avert liver disease progression in most HIV-coinfected patients, the lack of satisfactory treatment for hepatitis delta virus (HDV) infection remains a major threat for developing cirrhosis and liver cancer in this population. In the European Union (EU) and North America, sexual contact has replaced injection drug use that has been the major transmission route for HDV in HIV-positive persons. PegIFNα is the only a...
Source: AIDS - Category: Infectious Diseases Tags: Editorial Review Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cirrhosis | Coffee | Heart | Hepatitis | Hepatitis C | Infectious Diseases | Liver | Liver Disease | Study | Urology & Nephrology